Tandem chemo-mobilization followed by high-dose melphalan and carmustine with single autologous hematopoietic cell transplantation for multiple myeloma

A. I. Chen, R. S. Negrin, A. McMillan, J. A. Shizuru, L. J. Johnston, R. Lowsky, D. B. Miklos, S. Arai, W. K. Weng, G. G. Laport, K. Stockerl-Goldstein

Research output: Contribution to journalArticle

7 Scopus citations

Abstract

Single autologous hematopoietic cell transplant (AHCT) with high-dose melphalan prolongs survival in patients with multiple myeloma but is not curative. We conducted a study of intensive single AHCT using tandem chemo-mobilization with CY and etoposide followed by high-dose conditioning with melphalan 200 mg/m 2 plus carmustine 15 mg/kg. One hundred and eighteen patients in first consolidation (CON1) and 58 patients in relapse (REL) were transplanted using this intensified approach. Disease response improved from 32% very good PR (VGPR)+CR pre-mobilization to 76% VGPR+CR post transplant in CON1. With a median follow-up of 4.7 years, the median EFS was 2.8 years, and the median OS was 5.1 years in CON1. OS from time of transplant was significantly shorter for REL (3.4 years) compared with CON1 (5.1 years; P=0.02). However, OS from time of diagnosis was similar in REL (6.1 years) and CON1 (6.0 years; P=0.80). The 100-day non-relapse mortality in the CON1 and REL groups was 0% and 7%, respectively. In summary, intensified single AHCT with tandem chemo-mobilization and augmented high-dose therapy is feasible in multiple myeloma and leads to high-quality response rates.

Original languageEnglish (US)
Pages (from-to)516-521
Number of pages6
JournalBone marrow transplantation
Volume47
Issue number4
DOIs
StatePublished - Apr 2012

Keywords

  • autologous
  • myeloma
  • transplant

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Fingerprint Dive into the research topics of 'Tandem chemo-mobilization followed by high-dose melphalan and carmustine with single autologous hematopoietic cell transplantation for multiple myeloma'. Together they form a unique fingerprint.

  • Cite this

    Chen, A. I., Negrin, R. S., McMillan, A., Shizuru, J. A., Johnston, L. J., Lowsky, R., Miklos, D. B., Arai, S., Weng, W. K., Laport, G. G., & Stockerl-Goldstein, K. (2012). Tandem chemo-mobilization followed by high-dose melphalan and carmustine with single autologous hematopoietic cell transplantation for multiple myeloma. Bone marrow transplantation, 47(4), 516-521. https://doi.org/10.1038/bmt.2011.106